Loading…
Metformin prevents airway hyperreactivity in rats with dietary obesity
Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and fem...
Saved in:
Published in: | American journal of physiology. Lung cellular and molecular physiology 2021-12, Vol.321 (6), p.L1105-L1118 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793 |
container_end_page | L1118 |
container_issue | 6 |
container_start_page | L1105 |
container_title | American journal of physiology. Lung cellular and molecular physiology |
container_volume | 321 |
creator | Calco, Gina N Proskocil, Becky J Jacoby, David B Fryer, Allison D Nie, Zhenying |
description | Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma. |
doi_str_mv | 10.1152/ajplung.00202.2021 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2605304426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</originalsourceid><addsrcrecordid>eNpVkF9LwzAUxYMobk6_gA9S8Lnz5n_6Iog4FSa-6HNIu3TL2Nqaphv99mZuDn0IN-Sce3L4IXSNYYwxJ3dm2ay6aj4GIEDG8eATNIwCSTEHdhrvwCAFAXyALtp2CQAcQJyjAWVCKIb5EE3ebChrv3ZV0ni7sVVoE-P81vTJom-s99YUwW1c6JNo8SbKWxcWyczZYHyf1Llto3iJzkqzau3VYY7Q5-Tp4_Elnb4_vz4-TNOCUQhpXhYzZaUwPE4sc0mLTCrBMkGwEsIKzJQpWHyTIEnOqYXMKsoxE9QomdERut_nNl2-trMi9vVmpRvv1rGNro3T_5XKLfS83mglIxMCMeD2EODrr862QS_rzlexsyYRFAXGiIgusncVvm5bb8vjDxj0jr0-sNc_7PWOfVy6-dvtuPILm34Dr_uCMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605304426</pqid></control><display><type>article</type><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><source>American Physiological Society Free</source><creator>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</creator><creatorcontrib>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</creatorcontrib><description>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</description><identifier>ISSN: 1040-0605</identifier><identifier>EISSN: 1522-1504</identifier><identifier>DOI: 10.1152/ajplung.00202.2021</identifier><identifier>PMID: 34668415</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antidiabetics ; Asthma ; Asthma - chemically induced ; Asthma - drug therapy ; Asthma - metabolism ; Asthma - pathology ; Body fat ; Body weight ; Body weight gain ; Bradycardia ; Bronchial Hyperreactivity - chemically induced ; Bronchial Hyperreactivity - drug therapy ; Bronchial Hyperreactivity - metabolism ; Bronchial Hyperreactivity - pathology ; Bronchoconstriction ; Bronchoconstrictor Agents - toxicity ; Diabetes mellitus ; Diet ; Diet, High-Fat - adverse effects ; Fasting ; Female ; Glucose ; Glucose - metabolism ; High fat diet ; Hyperinsulinism - etiology ; Hyperinsulinism - metabolism ; Hyperinsulinism - pathology ; Hyperinsulinism - prevention & control ; Hypersensitivity ; Hypoglycemic Agents - pharmacology ; Insulin ; Insulin resistance ; Laboratory testing ; Low fat diet ; Male ; Males ; Metformin ; Metformin - pharmacology ; Methacholine ; Methacholine Chloride - toxicity ; Nutrient deficiency ; Obesity ; Obesity - complications ; Potentiation ; Rats ; Rats, Sprague-Dawley ; Respiratory tract ; Rodents ; Vagus nerve ; Vagus Nerve - drug effects ; Weight Gain ; Weight reduction</subject><ispartof>American journal of physiology. Lung cellular and molecular physiology, 2021-12, Vol.321 (6), p.L1105-L1118</ispartof><rights>Copyright American Physiological Society Dec 2021</rights><rights>Copyright © 2021 the American Physiological Society. 2021 American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</citedby><cites>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</cites><orcidid>0000-0002-2521-5580 ; 0000-0003-1712-9831 ; 0000-0002-7803-6447 ; 0000-0001-6387-1813 ; 0000-0003-2195-9512</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Calco, Gina N</creatorcontrib><creatorcontrib>Proskocil, Becky J</creatorcontrib><creatorcontrib>Jacoby, David B</creatorcontrib><creatorcontrib>Fryer, Allison D</creatorcontrib><creatorcontrib>Nie, Zhenying</creatorcontrib><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><title>American journal of physiology. Lung cellular and molecular physiology</title><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><description>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</description><subject>Animals</subject><subject>Antidiabetics</subject><subject>Asthma</subject><subject>Asthma - chemically induced</subject><subject>Asthma - drug therapy</subject><subject>Asthma - metabolism</subject><subject>Asthma - pathology</subject><subject>Body fat</subject><subject>Body weight</subject><subject>Body weight gain</subject><subject>Bradycardia</subject><subject>Bronchial Hyperreactivity - chemically induced</subject><subject>Bronchial Hyperreactivity - drug therapy</subject><subject>Bronchial Hyperreactivity - metabolism</subject><subject>Bronchial Hyperreactivity - pathology</subject><subject>Bronchoconstriction</subject><subject>Bronchoconstrictor Agents - toxicity</subject><subject>Diabetes mellitus</subject><subject>Diet</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Fasting</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose - metabolism</subject><subject>High fat diet</subject><subject>Hyperinsulinism - etiology</subject><subject>Hyperinsulinism - metabolism</subject><subject>Hyperinsulinism - pathology</subject><subject>Hyperinsulinism - prevention & control</subject><subject>Hypersensitivity</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Laboratory testing</subject><subject>Low fat diet</subject><subject>Male</subject><subject>Males</subject><subject>Metformin</subject><subject>Metformin - pharmacology</subject><subject>Methacholine</subject><subject>Methacholine Chloride - toxicity</subject><subject>Nutrient deficiency</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Potentiation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Respiratory tract</subject><subject>Rodents</subject><subject>Vagus nerve</subject><subject>Vagus Nerve - drug effects</subject><subject>Weight Gain</subject><subject>Weight reduction</subject><issn>1040-0605</issn><issn>1522-1504</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkF9LwzAUxYMobk6_gA9S8Lnz5n_6Iog4FSa-6HNIu3TL2Nqaphv99mZuDn0IN-Sce3L4IXSNYYwxJ3dm2ay6aj4GIEDG8eATNIwCSTEHdhrvwCAFAXyALtp2CQAcQJyjAWVCKIb5EE3ebChrv3ZV0ni7sVVoE-P81vTJom-s99YUwW1c6JNo8SbKWxcWyczZYHyf1Llto3iJzkqzau3VYY7Q5-Tp4_Elnb4_vz4-TNOCUQhpXhYzZaUwPE4sc0mLTCrBMkGwEsIKzJQpWHyTIEnOqYXMKsoxE9QomdERut_nNl2-trMi9vVmpRvv1rGNro3T_5XKLfS83mglIxMCMeD2EODrr862QS_rzlexsyYRFAXGiIgusncVvm5bb8vjDxj0jr0-sNc_7PWOfVy6-dvtuPILm34Dr_uCMg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Calco, Gina N</creator><creator>Proskocil, Becky J</creator><creator>Jacoby, David B</creator><creator>Fryer, Allison D</creator><creator>Nie, Zhenying</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2521-5580</orcidid><orcidid>https://orcid.org/0000-0003-1712-9831</orcidid><orcidid>https://orcid.org/0000-0002-7803-6447</orcidid><orcidid>https://orcid.org/0000-0001-6387-1813</orcidid><orcidid>https://orcid.org/0000-0003-2195-9512</orcidid></search><sort><creationdate>20211201</creationdate><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><author>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antidiabetics</topic><topic>Asthma</topic><topic>Asthma - chemically induced</topic><topic>Asthma - drug therapy</topic><topic>Asthma - metabolism</topic><topic>Asthma - pathology</topic><topic>Body fat</topic><topic>Body weight</topic><topic>Body weight gain</topic><topic>Bradycardia</topic><topic>Bronchial Hyperreactivity - chemically induced</topic><topic>Bronchial Hyperreactivity - drug therapy</topic><topic>Bronchial Hyperreactivity - metabolism</topic><topic>Bronchial Hyperreactivity - pathology</topic><topic>Bronchoconstriction</topic><topic>Bronchoconstrictor Agents - toxicity</topic><topic>Diabetes mellitus</topic><topic>Diet</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Fasting</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose - metabolism</topic><topic>High fat diet</topic><topic>Hyperinsulinism - etiology</topic><topic>Hyperinsulinism - metabolism</topic><topic>Hyperinsulinism - pathology</topic><topic>Hyperinsulinism - prevention & control</topic><topic>Hypersensitivity</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Laboratory testing</topic><topic>Low fat diet</topic><topic>Male</topic><topic>Males</topic><topic>Metformin</topic><topic>Metformin - pharmacology</topic><topic>Methacholine</topic><topic>Methacholine Chloride - toxicity</topic><topic>Nutrient deficiency</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Potentiation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Respiratory tract</topic><topic>Rodents</topic><topic>Vagus nerve</topic><topic>Vagus Nerve - drug effects</topic><topic>Weight Gain</topic><topic>Weight reduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Calco, Gina N</creatorcontrib><creatorcontrib>Proskocil, Becky J</creatorcontrib><creatorcontrib>Jacoby, David B</creatorcontrib><creatorcontrib>Fryer, Allison D</creatorcontrib><creatorcontrib>Nie, Zhenying</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calco, Gina N</au><au>Proskocil, Becky J</au><au>Jacoby, David B</au><au>Fryer, Allison D</au><au>Nie, Zhenying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin prevents airway hyperreactivity in rats with dietary obesity</atitle><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>321</volume><issue>6</issue><spage>L1105</spage><epage>L1118</epage><pages>L1105-L1118</pages><issn>1040-0605</issn><eissn>1522-1504</eissn><abstract>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>34668415</pmid><doi>10.1152/ajplung.00202.2021</doi><orcidid>https://orcid.org/0000-0002-2521-5580</orcidid><orcidid>https://orcid.org/0000-0003-1712-9831</orcidid><orcidid>https://orcid.org/0000-0002-7803-6447</orcidid><orcidid>https://orcid.org/0000-0001-6387-1813</orcidid><orcidid>https://orcid.org/0000-0003-2195-9512</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1040-0605 |
ispartof | American journal of physiology. Lung cellular and molecular physiology, 2021-12, Vol.321 (6), p.L1105-L1118 |
issn | 1040-0605 1522-1504 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715020 |
source | American Physiological Society Free |
subjects | Animals Antidiabetics Asthma Asthma - chemically induced Asthma - drug therapy Asthma - metabolism Asthma - pathology Body fat Body weight Body weight gain Bradycardia Bronchial Hyperreactivity - chemically induced Bronchial Hyperreactivity - drug therapy Bronchial Hyperreactivity - metabolism Bronchial Hyperreactivity - pathology Bronchoconstriction Bronchoconstrictor Agents - toxicity Diabetes mellitus Diet Diet, High-Fat - adverse effects Fasting Female Glucose Glucose - metabolism High fat diet Hyperinsulinism - etiology Hyperinsulinism - metabolism Hyperinsulinism - pathology Hyperinsulinism - prevention & control Hypersensitivity Hypoglycemic Agents - pharmacology Insulin Insulin resistance Laboratory testing Low fat diet Male Males Metformin Metformin - pharmacology Methacholine Methacholine Chloride - toxicity Nutrient deficiency Obesity Obesity - complications Potentiation Rats Rats, Sprague-Dawley Respiratory tract Rodents Vagus nerve Vagus Nerve - drug effects Weight Gain Weight reduction |
title | Metformin prevents airway hyperreactivity in rats with dietary obesity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A00%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin%20prevents%20airway%20hyperreactivity%20in%20rats%20with%20dietary%20obesity&rft.jtitle=American%20journal%20of%20physiology.%20Lung%20cellular%20and%20molecular%20physiology&rft.au=Calco,%20Gina%20N&rft.date=2021-12-01&rft.volume=321&rft.issue=6&rft.spage=L1105&rft.epage=L1118&rft.pages=L1105-L1118&rft.issn=1040-0605&rft.eissn=1522-1504&rft_id=info:doi/10.1152/ajplung.00202.2021&rft_dat=%3Cproquest_pubme%3E2605304426%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2605304426&rft_id=info:pmid/34668415&rfr_iscdi=true |